Preliminary results from a placebo-controlled trial of the antibiotic minocycline in children with fragile X syndrome suggest the drug alleviates some aspects of the disorder, according to research presented Friday at the International Meeting for Autism Research in Toronto.
Spectrum: Autism Research News
International Meeting for Autism Research 2012
Neuroscience funding has plateaued, so researchers need to squeeze every drop from existing data.
By studying pregnant women who already have a child with autism, researchers hope to understand how epigenetic changes — those that affect gene expression but don’t directly alter DNA — during pregnancy influences risk of the disorder.
Two new studies on oxytocin, the so-called ‘trust hormone,’ suggest new avenues for using the drug to treat autism.